This is not a technology choice. It is the most structuring trade-off a leader can make in the AI era. It determines your dependencies, your competitive advantage and your capacity to pivot in 5 years.
Most companies make this decision without seeing the dependencies they are creating.
Building internally means betting on scarce talent and long timelines. Buying means accepting vendor dependency on data, models and contractual terms you don't control. Partnering means sharing value and potentially critical process visibility with a third party whose interests are not aligned with yours.
Most executive teams choose based on immediate cost or speed of deployment. These are the wrong criteria. The right criteria are: which dependencies does this create, and under what conditions can we exit in 3 years?
Once contracts are signed, processes embedded and teams trained : going back is no longer a realistic option. It is no longer a trade-off. It is a constraint.
We produce a complete strategic reading of the trade-off: mapping of dependencies created by each scenario, exit cost evaluation, identification of the option that best preserves competitive advantage and the capacity to reorient. Not a technical recommendation. A structured strategic decision.
We intervene before the decision is made, not after. Once contracts are signed and teams engaged, dependencies are structural. The window to arbitrate correctly closes fast.
Once the decision is made, it is rarely reversible. We don't intervene to undo what is done : we intervene so you clearly see what you are about to create.
The build/buy/partner trade-off is the decision by which an organisation chooses to build an AI capability internally, purchase an existing market solution, or partner with a third party to develop it jointly. It is one of the most structuring decisions in AI-era corporate strategy.
Each option creates technological dependencies of a different nature. The build strategy preserves sovereignty over data and models but exposes the organisation to talent risk and delay. The buy strategy accelerates deployment but creates vendor dependency that can become structural if proprietary data feeds the external model. The partner strategy shares risk but potentially exposes critical processes to a third party whose interests may diverge over time.
Rational arbitration criteria include: the exit cost (at what cost can you change option in 3 years), the criticality of the data involved, the level of competitive differentiation delivered, and compatibility with EU AI Act obligations. A decision made without these criteria typically results in absorbed dependency rather than chosen dependency.
We intervene before signing to produce the complete strategic reading: dependencies created, real exit cost, EU AI Act exposure, capacity to pivot in 3 years.
let's talk